Investor Webcast Scheduled for 8:00 am ETPRINCETON, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS ...
National Cancer Institute Director Anthony Letai, M.D., Ph.D., has attempted to fight back against the “misinformation” surrounding a perceived fall in federal cancer research budgets, insisting that ...
At just 19 years old, the first-year student was the only undergraduate selected to present research at a workshop hosted by ...
The LSU LCMC Health Cancer Center has strategically expanded its Cancer Clinical Trials Office, reinforcing its commitment to ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
In a new study, scientists at Cleveland Clinic discovered that hormones associated with male development may play a key role ...
Senior Living segment adjusted EBITDAR from operations for the first quarter was $16.3 million, an increase of $1.8 million or 12.6% over the prior year quarter; and segment adjusted EBITDA from ...
During these uncertain times, our strategy is to stay anchored to what we control - disciplined capital allocation, safe and ...
The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug ...
Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results